Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J LAHAM

Showing results (91-100 of 168) with videos related to

Pageof 17
Sort By:
The American Journal of Physiology|October 10, 1997
Hemodynamic effects of intracoronary VEGF delivery: evidence of tachyphylaxis and NO dependence of responseJ J Lopez, R J Laham, J P Carrozza, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 9, 2008
Exercise-induced expression of VEGF and salvation of myocardium in the early stage of myocardial infarctionGuifu Wu, Jamal S Rana, Joanna Wykrzykowska, et al.
The American Journal of Medicine|March 23, 2020
Cognition, Frailty, and Functional Outcomes of Transcatheter Aortic Valve ReplacementMeera Kapadia, Sandra M Shi, Jonathan Afilalo, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 17, 2008
Endostatin and angiostatin are increased in diabetic patients with coronary artery disease and associated with impaired coronary collateral formationNeel R Sodha, Richard T Clements, Munir Boodhwani, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 1, 2010
Effects of selective cyclooxygenase-2 and nonselective cyclooxygenase inhibition on ischemic myocardiumMichael P Robich, Louis M Chu, Jun Feng, et al.
Circulation|March 17, 2004
PR39 inhibits apoptosis in hypoxic endothelial cells: role of inhibitor apoptosis protein-2Jiaping Wu, Cherie Parungo, Guifu Wu, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 20, 2000
Intrapericardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemiaR J Laham, M Rezaee, M Post, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 2, 2002
Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 proteinMarc Ruel, Roger J Laham, J Anthony Parker, et al.
Nature Communications|March 29, 2023
Activation of the CA2-ventral CA1 pathway reverses social discrimination dysfunction in Shank3B knockout miceElise C Cope, Samantha H Wang, Renée C Waters, et al.
JACC. Case Reports|March 12, 2025
Successful Percutaneous Extraction of a WATCHMAN FLX Device From the Left Ventricular Outflow TractEvelyn Goodyear, Aaron Kunamalla, Enrico G Ferro, et al.
Pageof 17

Showing results (91-100 of 168) with videos related to

Sort By:
Pageof 17
The American Journal of Physiology|October 10, 1997
Hemodynamic effects of intracoronary VEGF delivery: evidence of tachyphylaxis and NO dependence of responseJ J Lopez, R J Laham, J P Carrozza, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 9, 2008
Exercise-induced expression of VEGF and salvation of myocardium in the early stage of myocardial infarctionGuifu Wu, Jamal S Rana, Joanna Wykrzykowska, et al.
The American Journal of Medicine|March 23, 2020
Cognition, Frailty, and Functional Outcomes of Transcatheter Aortic Valve ReplacementMeera Kapadia, Sandra M Shi, Jonathan Afilalo, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 17, 2008
Endostatin and angiostatin are increased in diabetic patients with coronary artery disease and associated with impaired coronary collateral formationNeel R Sodha, Richard T Clements, Munir Boodhwani, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 1, 2010
Effects of selective cyclooxygenase-2 and nonselective cyclooxygenase inhibition on ischemic myocardiumMichael P Robich, Louis M Chu, Jun Feng, et al.
Circulation|March 17, 2004
PR39 inhibits apoptosis in hypoxic endothelial cells: role of inhibitor apoptosis protein-2Jiaping Wu, Cherie Parungo, Guifu Wu, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 20, 2000
Intrapericardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemiaR J Laham, M Rezaee, M Post, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 2, 2002
Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 proteinMarc Ruel, Roger J Laham, J Anthony Parker, et al.
Nature Communications|March 29, 2023
Activation of the CA2-ventral CA1 pathway reverses social discrimination dysfunction in Shank3B knockout miceElise C Cope, Samantha H Wang, Renée C Waters, et al.
JACC. Case Reports|March 12, 2025
Successful Percutaneous Extraction of a WATCHMAN FLX Device From the Left Ventricular Outflow TractEvelyn Goodyear, Aaron Kunamalla, Enrico G Ferro, et al.
Pageof 17